StarpharmaのSMA 200
StarpharmaのSMA 200は何ですか。
Starpharma Holdings LimitedのSMA 200はAUD$0 -20.29%です。
SMA 200の定義は何ですか。
SMA 200は、過去200日間の終値の非加重平均として計算された過去200日間の平均株価です。
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
ASXのセクタHealth CareにおけるSMA 200の企業と比べるStarpharma
Starpharmaは何をしますか。
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Starpharmaと類似のsma 200
- Tenth Avenue PetroleumのSMA 200はCAD$0 -11.04%です。
- Values Cultural Invest LtdのSMA 200は$0 -15.69%です。
- Zhong AnのSMA 200はHKD$0 -11.07%です。
- Bossini InternationalのSMA 200はHKD$0 -61.07%です。
- A & S ()のSMA 200はHKD$0 -6.27%です。
- LEONI AGのSMA 200は€0 -179.87%です。
- StarpharmaのSMA 200はAUD$0 -20.29%です。
- Gamesquare EsportsのSMA 200は$0 +17.04%です。
- Anson ResourcesのSMA 200はAUD$0 -15.52%です。
- Timberline ResourcesのSMA 200はCAD$0 +13.75%です。
- Sientra IncのSMA 200は$0 +33.93%です。
- Mkango ResourcesのSMA 200はCAD$0 -2.15%です。
- Excellon ResourcesのSMA 200は$0 -87.53%です。